Skip to content

Newsroom

Welcome to Orion's newsroom where you can find the latest releases and articles.

Stock exchange releases

5/2/2025 301,521 Orion Corporation A shares converted into B shares
4/24/2025 Composition of the Nomination Committee of Orion Corporation
4/23/2025 Orion Group Interim Report January–March 2025
4/10/2025 The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence

All releases 

Press releases

6/3/2025 U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
5/23/2025 Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market
5/22/2025 Orion to host Capital Markets Day today, 22 May 2025, in Helsinki
5/21/2025 Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers

All releases 

Subscribe to releases

Subscribe Orion Corporation's stock exchange and press releases to your e-mail.

Subscribe

Content themes

Orion Pharma content bank

You can find and download Orion Pharma brand assets in the content bank.

Sign in or registrate

Corporate Communications

Terhi Ormio

Vice President, Communications; primary media contact

terhi.ormio@orion.fi

+358104264646
Tuukka Hirvonen

Head of Investor Relations

tuukka.hirvonen@orion.fi

+358104262721
Mari Lautsuo

Communications Manager

mari.lautsuo@orion.fi

+358104262156
Valtteri Manninen

Communications Manager

valtteri.manninen@orion.fi

+358104262303
Verna Vuorinen

Communications Specialist

verna.vuorinen@orion.fi

+358104262211

Disclosure policy

In its communications, Orion Corporation complies with valid legislation, the rules and insider guidelines of Nasdaq Helsinki Ltd, the regulations and guidelines of the Financial Supervisory Authority and the instructions and principles defined internally in the company.